Intraoperative lymphatic mapping techniques for endometrial cancer

Expert Review of Anticancer Therapy

Volumn 11, Issue 1, 2011, Pages 83-93

  Mais, Valerio ^a   Cirronis, Maria Giuseppina ^a   Piras, Bruno ^a   Silvetti, Enrico ^a   Cossu, Ester ^a   Melis, Gian Benedetto ^a  

^a University Hospital San Giovanni di Dio   (Italy)

Author keywords

endometrial cancer; gynecological cancers; lymphadenectomy; lymphatic mapping; micrometastases; sentinel lymph node; surgical staging

Indexed keywords

DISULFINE BLUE; HUMAN SERUM ALBUMIN TC 99M; ISOSULFAN BLUE; METHYLENE BLUE; NANOCOLL TC 99M; RADIOISOTOPE; TECHNETIUM SULFUR COLLOID TC 99M;

ANAPHYLAXIS; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; ENDOMETRIUM CANCER; FALSE NEGATIVE RESULT; GYNECOLOGIC CANCER; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE LYMPHATIC MAPPING; INTRAOPERATIVE PERIOD; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM EXAMINATION; LYMPHOSCINTIGRAPHY; MELANOMA; MICROMETASTASIS; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PREOPERATIVE EVALUATION; REVIEW; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVIX CANCER; VULVA CANCER;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 78650472336     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.181     Document Type: Review

References (68)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 60(5), 277-300 (2010).
2. Fanning J, Evans MC, Peters AJ, Samuel M, Harmon ER, Bates JS. Endometrial adenocarcinoma histologic subtypes: clinical and pathologic profle. Gynecol. Oncol. 32(3), 288-291 (1989).
3. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC. Current issues in the management of endometrial cancer. Mayo Clin. Proc. 83(1), 97-112 (2008).
4. Santin AD, Bellone S, O'Brien TJ, Pecorelli S, Cannon MJ, Roman JJ. Current treatment options for endometrial cancer. Expert Rev. Anticancer Ther. 4(4), 679-689 (2004).
5. Hamilton CA, Cheung MK, Osann K et al Uterine papillary serous and clear cell carcinomas predict for poorer survival compared with grade 3 endometrioid corpus cancers. Br. J. Cancer 94(5), 642-646 (2006).
6. Mourits MJ, Bijen CB, Arts HJ et al. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial. Lancet Oncol. 11(8), 763-771 (2010)
7. Cardenas-Goicoechea J, Adams S, Bhat SB, Randall TC. Surgical outcomes of robotic-assisted surgical staging for endometrial cancer are equivalent to traditional laparoscopic staging at a minimally invasive surgical center. Gynecol. Oncol. 117(2), 224-228 (2010).
8. Frumovitz M, Gershenson DM. Fertility-sparing therapy for young women with endometrial cancer. Expert Rev. Anticancer Ther. 6(1), 27-32 (2006).
9. Fiorelli JL, Herzog TJ, Wright JD. Current treatment strategies for endometrial cancer. Expert Rev. Anticancer Ther. 8(7), 1149-1157 (2008).
10. Creasman WT, Morrow CP, Bundy BN et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 60(8 Suppl.), 2035-2041 (1987).
11. Creasman WT, Odicino F, Maisonneuve P et al. Carcinoma of the corpus uteri. J. Epidemiol. Biostat. 6(1), 47-86 (2001).
12. Odicino F, Pecorelli S, Zigliani L, Creasman WT. History of the FIGO cancer staging system. Int. J. Gynaecol Obstet. 101(2), 205-210 (2008).
13. Creasman W Revised FIGO staging for carcinoma of the endometrium. Int. J. Gynaecol. Obstet. 105(2), 109 (2009).
14. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet. 105(2), 103-104 (2009).
15. Mariani A, Dowdy SC, Podratz KC. New surgical staging of endometrial cancer: 20 years later. Int. J. Gynaecol Obstet. 105(2), 110-111 (2009).
16. Mariani A, Dowdy SC, Cliby WA et al Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol. Oncol. 109(1), 11-18 (2008).
17. Yoon JH, Yoo SC, Kim WY, Chang SJ, Chang KH, Ryu HS. Para-aortic lymphadenectomy in the management of preoperative grade 1 endometrial cancer confned to the uterine corpus. Ann. Surg. Oncol. DOI: 10.1245/s10434-010-1199- 1195 (2010) (Epub ahead of print).
18. Kilgore LC, Partridge EE, Alvarez RD et al. Adenocarcinoma of the endometrium: survival comparison of patients with and without pelvis node sampling. Gynecol. Oncol. 56(1), 29-33 (1995).
19. May K, Bryant A, Dickinson HO, Kehoe S, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst. Rev. 1, CD007585 (2010).
20. Benedetti Panici P, Basile S, Maneschi F et al Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J. Natl Cancer Inst. 100(23), 1707-1716 (2008).
21. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Effcacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658), 125-136 (2009).
22. Uccella S, Podratz KC, Aletti GD, Mariani A. Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J. Natl Cancer Inst. 101(12), 897-898 (2009).
23. Creasman WT, Mutch DE, Herzog TJ. ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol. Oncol. 116(3), 293-294 (2010).
24. Kwon JS, Qiu F, Saskin R, Carey MS. Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer? Obstet. Gynecol. 114(4), 736-743 (2009).
25. Oonk MHM, van de Nieuwenhof HP, Van Der Zee AGJ, de Hullu JA. Update on the sentinel lymph node procedure in vulvar cancer. Expert Rev. Anticancer Ther. 10(1), 61-69 (2010).
26. Gould EA, Winship T, Philbin PH, Kerr H. Observations on a "sentinel node" in the parotid. Cancer 13, 77-78 (1960).
27. Van der Zee AG, Oonk MH, de Hullu JA et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J. Clin. Oncol. 26(6), 884-889 (2008).
28. Kara PP, Ayahan A, Caner B et al. Analysis of dendritic cells in sentinel lymph nodes of patients with endometrial and patients with cervical cancers. Int. J. Gynecol. Cancer 19(7), 1239-1243 (2009).
29. Quan ML, McCready D. The evolution of lymph node assessment in breast cancer. J. Surg. Oncol. 99(4), 194-198 (2009).
30. Stadelmann WK. The role of lymphatic mapping and sentinel lymph node biopsy in the staging and treatment of melanoma. Clin. Plast. Surg. 37(1), 79-99 (2010).
31. Gortzak-Uzan L, Jimenez W, Nofech-Mozes S et al. Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? Gynecol. Oncol. 116(1), 28-32 (2010).
32. Fader AN, Edwards RP, Cost M et al. Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecol. Oncol. 111(1), 13-17 (2008).
33. Marchiolè P, Buenerd A, Scoazec JY, Dargent D, Mathevet P. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 100(10), 2154-2159 (2004). (Pubitemid 38580334)
34. El-Ghobashy AE, Saidi SA. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications. Eur. J. Surg Oncol. 35(7), 675-685 (2009).
35. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymph adenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol. Oncol. 62(2), 169-173 (1996).
36. Frumovitz M, Bodurka DC, Broaddus RR et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol. Oncol. 104(1), 100-103 (2007).
37. Echt ML, Finan MA, Hoffman MS, Kline RC, Roberts WS, Fiorica JV. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South. Med. J. 92(2), 204-208 (1999).
38. Holub Z, Jabor A, Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur. J. Gynaecol. Oncol. 23(1), 53-57 (2002).
39. Gien LT, Kwon JS, Carey MS. Sentinel node mapping with isosulfan blue dye in endometrial cancer. J. Obstet. Gynaecol. Can. 27(12), 1107-1112 (2005).
40. Altgassen C, Pagenstecher J, Hornung D, Diedrich K, Hornemann A. A new approach to label sentinel nodes in endometrial cancer. Gynecol. Oncol. 105, 457-461 (2007).
41. Li B, Li XG, Wu LY et al. A pilot study of sentinel lymph nodes identifcation in patients with endometrial cancer. Bull. Cancer 94(1), E1-E4 (2007).
42. Lopes LA, Nicolau SM, Baracat FF et al. Sentinel lymph node in endometrial cancer. Int. J. Gynecol. Cancer 17(5), 1113-1117 (2007).
43. Niikura H, Okamura C, Utsunomiya H et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol. Oncol. 92(2), 669-674 (2004).
44. Fersis N, Gruber I, Relakis K et al. Sentinel node identifcation and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur. J. Gynaecol. Oncol. 25(3), 339-342 (2004).
45. Vidal-Sicart S, Doménech B, Lujan B et al. Sentinel node in gynecological cancers. Our experience. Rev. Esp. Med. Nucl. 28(5), 221-228 (2009).
46. Feranec R, Mouková L, Stanícek J, Stefániková L, Chovanec J. Sentinel lymph node identifcation using hysteroscopy in patients with endometrial cancer. Klin. Onkol. 23(2), 92-98 (2010).
47. 99mTc colloid and blue dye in patients with endometrial cancer. Tumori 88(3), S9-S10 (2002).
48. Gargiulo T, Giusti M, Bottero M et al. Sentinel lymph node (SLN) laparoscopic assessment in early stage endometrial cancer. Minerva Gynecol. 55(3), 259-262 (2003).
49. Pelosi E, Arena V, Baudino B et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl. Med. Commun. 24(9), 971-975 (2003).
50. Barranger E, Cortez A, Grahek D, Callard P, Uzan S, Darai E. Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer. Ann. Surg. Oncol. 11(3), 344-349 (2004).
51. Lelievre L, Camatte S, Le Frere-Belda MA et al. Sentinel lymph node biopsy in cervix and corpus uteri cancers. Int. J. Gynecol. Cancer 14(2), 271-278 (2004).
52. Raspagliesi F, Ditto A, Kusamura S et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. Am. J. Obstet. Gynecol. 191(2), 435-439 (2004).
53. 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur. J. Nucl. Med. Mol. Imaging 32(5), 569-574 (2005).
54. Bats AS, Clément D, Larousserie F et al. Is sentinel node biopsy feasible in endometrial cancer? Results in 26 patients. J. Gynecol. Obstet. Biol. Reprod. (Paris) 34(5), 768-774 (2005).
55. Depelch Y, Cortez A, Coutant C et al. The sentinel concept in endometrial cancer: histopatologic validation by serial section and immunohistochemistry. Ann. Oncol. 18(11), 1799-1803 (2007).
56. Bats AS, Clément D, Larousserie F et al. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J. Surg. Oncol. 97(2), 141-145 (2008).
57. Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E. Use of the sentinel node procedure to stage endometrial cancer. Ann. Surg. Oncol. 15(5), 1523-1529 (2008).
58. Barranger E, Depelch Y, Coutant C, Dubernard G, Uzan S, Darai E. Laparoscopic sentinel node mapping using combined detection for endometrial cancer: a study of 33 cases -is it a promising technique? Am. J. Surg. 197(1), 1-7 (2009).
59. Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N et al. Sentinel node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol. Oncol. 113(2), 163-169 (2009).
60. Khoury-Collado F, Glaser GE, Zivanovic O et al. Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? Gynecol. Oncol. 115(3), 453-455 (2009).
61. Delaloye JF, Pampallona S, Chardonnens E et al. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol. 106(1), 89-93 (2007).
62. Perrone AM, Casadio P, Formelli G et al Cervical and hysteroscopic injection for identifcation of sentinel lymph node in endometrial cancer. Gynecol. Oncol. 111(1), 62-67 (2008).
63. Robova H, Charvat M, Strnad P et al Lymphatic mapping in endometrial cancer: comparison of hysteroscopic and subserosal injection and the distribution of sentinel lymph nodes. Int. J. Gynecol. Cancer 19(3), 391-394 (2009).
64. Mais V, Peiretti M, Gargiulo T, Parodo G, Cirronis MG, Melis GB. Intraoperative sentinel lymph node detection by vital die through laparoscopy or laparotomy in early endometrial cancer. J. Surg. Oncol. 101(5), 408-412 (2010).
65. Ballester M, Rouzier R, Coutant C, Kerrou K, Darai E. Limits of lymhoscintigraphy for sentinel node biopsy in women with endometrial cancer. Gynecol. Oncol. 112(2), 348-352 (2009).
66. Niikura H, Okamoto S, Yoshinaga K et al. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial camcer. Gynecol. Oncol 105(3), 683-686 (2007).
67. Levenback CF, van der Zee AG, Rob L et al. Sentinel lymph node biopsy in patients with gynecologic cancers: expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol. Oncol. 114(2), 151-156 (2009).
68. Ballester M, Koskas M, Coutant C et al. Does the use of the 2009 FIGO classifcation of endometrial cancer impact on indications of the sentinel node biopsy? BMC Cancer 10(1), 465 (2010).